Download Lung Cancer Ebook PDF

Lung Cancer

Lung Cancer
Textbook for General Practitioners

by Heine H. Hansen

  • Publisher : Springer Science & Business Media
  • Release : 2012-12-06
  • Pages : 58
  • ISBN : 3642760317
  • Language : En, Es, Fr & De
GET BOOK

The "Europe against Cancer" programme has, from its inception, emphasised the key role which general practitioners must play in the actions necessary to achieve its aim of reduc ing the incidence and the mortality from cancer in the European Community. General practitioners, because of their day-to-day direct and continuing contact with patients, playa role not only in primary prevention and education of patients, but also in motivating their patients to accept secondary prevention and screening, some of it carried out by general practitioners themselves. These preventive activities are in addition to their traditional role in the care and management of patients with cancer at home, and increas ingly, their role in active treatment. In view of the importance of the general practitioner in the "Europe against Cancer" pro gramme, the European Commission, with a view to providing general practitioners with up-to-date useful information, has sponsored the production of this series of publications on organ based cancers, especially written for general practitioners. MICHEL RICHONNIER Coordinator ofthe "Europe against Cancer" programme, Commission ofthe European Communities, Brussels Preface To decrease the death rate of lung cancer is today one of the major challenges of medical doctors all over the world. In Europe alone, one person is dying of lung cancer every two minutes. Accordingly, most physicians will regularly in their career be confronted with a patient being either suspect of or having a lung cancer.

Lung Cancer

Lung Cancer
A Book

by Jack A. Roth,James D. Cox,Waun Ki Hong

  • Publisher : John Wiley & Sons
  • Release : 2011-08-26
  • Pages : 480
  • ISBN : 1444358669
  • Language : En, Es, Fr & De
GET BOOK

Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.

Lung Cancer

Lung Cancer
Volume 1: Molecular Pathology Methods and Reviews

by Barbara Driscoll

  • Publisher : Humana
  • Release : 2013-08-16
  • Pages : 594
  • ISBN : 9781489939128
  • Language : En, Es, Fr & De
GET BOOK

The Methods in Molecular Medicine series is intended as a resource for both novice and experienced investigators attempting to diversify their tech- logical base in research. Lung Cancer: Volume 1: Molecular Pathology Me- ods and Reviews presents an overview of the current status of assays employed to detect and characterize the multitude of pathologies that contribute to the development of this deadly disease. As with all volumes in the Methods in Molecular Medicine series, the reader should find that each methods-based chapter provides clear instructions for the performance of various protocols, supplemented by additional technical notes that provide valuable insight. These notes are designed to enable the reader to acquire the techniques described with a proficiency not easily achieved by re- ing standard method formats. No volume can exhaustively cover every aspect of biological research and there will be gaps in this endeavor that one or another research group will id- tify. Each section herein could readily be expanded into a book in its own right. However, I have sought to include a spectrum of techniques that should allow for the acquisition of key skills in each area covered.

Principles and Practice of Lung Cancer

Principles and Practice of Lung Cancer
The Official Reference Text of the IASLC

by David P. Carbone,Harvey I. Pass,David H. Johnson,John D. Minna

  • Publisher : Lippincott Williams & Wilkins
  • Release : 2010
  • Pages : 1011
  • ISBN : 0781773652
  • Language : En, Es, Fr & De
GET BOOK

Thoroughly revised and updated, this Fourth Edition is the most comprehensive, current reference on lung cancer, with contributions from the world's foremost surgeons, radiation oncologists, medical oncologists, pulmonologists, and basic scientists. Coverage includes complete information on combined modality treatments for small cell and non-small cell lung cancer and on complications of treatment and management of metastases. Emphasis is also given to early detection, screening, prevention, and new imaging techniques. This edition has expanded thoracic oncology chapters including thymus, mesothelioma, and mediastinal tumors, more detailed discussion of targeted agents, and state-of-the-art information on newer techniques in radiotherapy. Other highlights include more international contributors and greater discussion of changes in lung cancer management in each region of the world. A new editor, Giorgio Scagliotti, MD from the University of Turin, has coordinated the accounts of European activities. A companion website includes the full text online and an image bank.

Lung Cancer: Your Questions, Expert Answers

Lung Cancer: Your Questions, Expert Answers
A Book

by Schiller

  • Publisher : Jones & Bartlett Learning
  • Release : 2017-11-15
  • Pages : 117
  • ISBN : 1284150275
  • Language : En, Es, Fr & De
GET BOOK

Lung Cancer: Your Questions, Expert Answers, Fourth Edition guides patients and their families through diagnosis, treatment and survivorship. Providing both the doctor’s and patient’s point of view, this book is a complete guide to understanding treatment options, post-treatment quality of life, sources of support, and much more.

Peptide Hormones in Lung Cancer

Peptide Hormones in Lung Cancer
A Book

by Klaus Havemann,George D. Sorenson,Clauss Gropp

  • Publisher : Springer Science & Business Media
  • Release : 2013-03-09
  • Pages : 248
  • ISBN : 3642825338
  • Language : En, Es, Fr & De
GET BOOK

The incidence of lung cancer has reached epidemic proportions throughout the civilized world. One indication of the dimensions of this problem is that in the United States lung cancer has become the leading cause of cancer death in women as well as men. In 1912 there was a "nearly complete consensus of opinion that primary malignant neoplasms of the lung (were one) of the rarest forms of disease," according to Adler. By 1937, however, it had become clear that the incidence of lung cancer was increasing significantly; this increase has been progressive ever since. It is now well known that some lung cancers give rise to a variety of hormones which, at times, produce clinical manifestations. The association of hormone production with a "nonendocrine" tumor raises many questions, the answers to which may shed some light on the etiology of this prevalent form of cancer. This fascinating prob lem has stimulated a wide variety of studies in both the clinical and the basic sciences. A number of the more recent studies in this field were discussed at the International Symposium on Peptide Hor mones and Lung Cancer held in Marburg, West Germany, on June 18-20, 1984. This volume contains the papers that were pre sented on this occasion.

Lung Cancer

Lung Cancer

by Anne-Marie C. Dingemans,Martin Reck,Virginie Westeel

  • Publisher : European Respiratory Society
  • Release : 2015-06-01
  • Pages : 288
  • ISBN : 1849840628
  • Language : En, Es, Fr & De
GET BOOK

Lung cancer is the most common cause of death from cancer worldwide – it is estimated to cause nearly one in five cancer deaths. Most lung cancer patients are diagnosed late and for many of them, there are currently no curative therapy options available, meaning long-term survival is still low. Nevertheless, enormous progress has been made in the field during the last decade. This Monograph provides a comprehensive overview of the current knowledge of and advances in lung cancer, covering areas such as: screening; tobacco control; COPD; diagnosis; therapy; and treatment of early stage lung cancer from both a surgeon’s and radiation oncologist’s perspective. Very recent achievements in innovative fields, such as targeted therapies and immunotherapies, are also discussed.

Lung Cancer

Lung Cancer
Volume 2: Diagnostic and Therapeutic Methods and Reviews

by Barbara Driscoll

  • Publisher : Humana
  • Release : 2013-08-19
  • Pages : 816
  • ISBN : 9781489944191
  • Language : En, Es, Fr & De
GET BOOK

This work, Lung Cancer, Volume 2: Diagnostic and Therapeutic Methods and Reviews, in the Methods in Molecular Medicine series presents an overview of the current status of those methods useful in the diagnosis and tre- ment of lung cancer—both as it exists in the clinic and as it is being revoluti- ized in the laboratory. The book is intended to serve as a resource for researchers wishing to increase their knowledge of current and cutting edge technologies, in order that their investigations into neoplasms of the lung may benefit from this enriched diversity of techniques and approaches. Owing to the complex nature of the disease and the variety of methods available to analyze and attack it, no volume attempting to define diagnostic and therapeutic approaches to lung cancer can ever be complete. The sheer number of investigators involved in lung cancer research guarantees that some aspect will be inadvertently excluded. However, I hope that the range of techniques included herein will serve to open up new avenues of investigation for both the novice and experienced researcher.

Contemporary Issues in Lung Cancer

Contemporary Issues in Lung Cancer
A Nursing Perspective

by Marilyn Haas

  • Publisher : Jones & Bartlett Learning
  • Release : 2003
  • Pages : 322
  • ISBN : 9780763719142
  • Language : En, Es, Fr & De
GET BOOK

In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. Contemporary Issues in Lung Cancer addresses all aspects of the disease from incidence, risk factors, and the biology of lung cancer, to the latest modes of treatment. Also discussed are controversies in the detection and screening of lung cancer, and the special issues facing individuals with lung cancer.

Lung Cancer

Lung Cancer
The Facts

by Christopher John Hacon Williams

  • Publisher : Oxford University Press, USA
  • Release : 1992
  • Pages : 148
  • ISBN : 9780192622501
  • Language : En, Es, Fr & De
GET BOOK

Lung cancer is primarily a disease of well-developed affluent countries. It is by far the most common cancer in men, and is poised to overtake breast cancer as the most common cancer in women. Yet, although it is common, preventable, and sometimes curable, very little information isavailable about what happens when you get it - which is when accessible information is most needed.In a clear, non-emotive style, this revised and updated new edition provides the answers to the questions patients with lung cancers or those involved with them are likely to ask. The first section describes the causes (and includes a chapter on stopping smoking), diagnosis, and progression of thedisease. There follows a section on the curative and symptomatic treatments available for the different types of lung cancer; and the third section, new for this edition, discusses the future prospects for the disease and its treatment. Also included are a glossary, a list of further reading, andan extensive list of addresses of organizations which can provide help and advice.

Guide to Targeted Therapies: Treatment Resistance in Lung Cancer

Guide to Targeted Therapies: Treatment Resistance in Lung Cancer
A Book

by Federico Cappuzzo

  • Publisher : Springer
  • Release : 2015-10-15
  • Pages : 67
  • ISBN : 3319207415
  • Language : En, Es, Fr & De
GET BOOK

This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide.

Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
A Book

by Anonim

  • Publisher : Unknown Publisher
  • Release : 2017
  • Pages : 329
  • ISBN : 9781496369529
  • Language : En, Es, Fr & De
GET BOOK

Bioinformatics of Non Small Cell Lung Cancer and the Ras Proto-Oncogene

Bioinformatics of Non Small Cell Lung Cancer and the Ras Proto-Oncogene
A Book

by Amita Kashyap,D. Bujamma,Naresh Babu M

  • Publisher : Springer
  • Release : 2014-09-08
  • Pages : 72
  • ISBN : 9814585084
  • Language : En, Es, Fr & De
GET BOOK

Cancer is initiated by activation of oncogenes or inactivation of tumor suppressor genes. Mutations in the K-ras proto-oncogene are responsible for 10–30% of adenocarcinomas. Clinical Findings point to a wide variety of other cancers contributing to lung cancer incidence. Such a scenario makes identification of lung cancer difficult and thus identifying its mechanisms can contribute to the society. Identifying unique conserved patterns common to contributing proto-oncogenes may further be a boon to Pharmacogenomics and pharmacoinformatics. This calls for ab initio/de novo drug discovery that in turn will require a comprehensive in silico approach of Sequence, Domain, Phylogenetic and Structural analysis of the receptors, ligand screening and optimization and detailed Docking studies. This brief involves extensive role of the RAS subfamily that includes a set of proteins, which cause an over expression of cancer-causing genes like M-ras and initiate tumour formation in lungs. SNP Studies and Structure based drug discovery will also be undertaken.

Lung Cancer and Personalized Medicine

Lung Cancer and Personalized Medicine
Current Knowledge and Therapies

by Aamir Ahmad,Shirish Gadgeel

  • Publisher : Springer
  • Release : 2015-12-14
  • Pages : 228
  • ISBN : 3319242237
  • Language : En, Es, Fr & De
GET BOOK

This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer—statistics and epidemiology of lung cancer—along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer—immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry. Chapters are written by some of the leading experts in the field, who provide a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. With a unique mix of topics, this volume summarizes the current state-of-knowledge on lung cancer and the available therapies.

Imaging of Lung Cancer, An Issue of Radiologic Clinics of North America - E-Book

Imaging of Lung Cancer, An Issue of Radiologic Clinics of North America - E-Book
A Book

by Ella A. Kazerooni,Baskaran Sundaram

  • Publisher : Elsevier Health Sciences
  • Release : 2012-09-30
  • Pages : 167
  • ISBN : 145574705X
  • Language : En, Es, Fr & De
GET BOOK

This issue gives the general radiologist a solid overview of lung cancer imaging techniques. CT screening for lung cancer is discussed, and the evaluation and management of indeterminate pulmonary nodules is reviewed. Revised TNM lung cancer staging, as well as the optimal imaging protocols for lung cancer staging (CT, MR and PET) are thoroughly examined. A multidisciplinary approach to tissue sampling and updated histopathologic classification of lung cancer are discussed. Image-guided ablative therapies for lung cancer are reviewed. Finally, future trends in lung cancer diagnosis and staging and genetics are reviewed, as well as novel biomarkers for lung cancer detection.

Lung Cancer

Lung Cancer
A Book

by Joseph Aisner

  • Publisher : Unknown Publisher
  • Release : 1985
  • Pages : 336
  • ISBN : 9876543210XXX
  • Language : En, Es, Fr & De
GET BOOK

Management of Lung Cancer in Older People

Management of Lung Cancer in Older People
A Book

by Cesare Gridelli,Riccardo A. Audisio

  • Publisher : Springer Science & Business Media
  • Release : 2013-04-15
  • Pages : 251
  • ISBN : 0857297937
  • Language : En, Es, Fr & De
GET BOOK

This book aims to provide an up-to-date review of the literature in each of the major areas relating to the management of older lung cancer patients, and makes recommendations for best practice and future research. The authors come from a broad geographic spread including the UK, mainland Europe and North America to ensure a worldwide relevance.

Lung Cancer:

Lung Cancer:
Prevention, Management, and Emerging Therapies

by David J. Stewart

  • Publisher : Springer Science & Business Media
  • Release : 2010-03-10
  • Pages : 538
  • ISBN : 9781607615248
  • Language : En, Es, Fr & De
GET BOOK

Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. It kills almost as many Americans as cancers of the breast, prostate, colon, rectum, pancreas, and 2 kidney combined, and accounts for 28.6% of all US cancer deaths. With an increase in the 5-year relative survival rate from 13% to only 16% in the more than 2 30 years from 1974 to the present, it will take us another 840 years to eradicate lung cancer deaths if we do not improve the current rate of progress. As discussed in this text, lung cancer prevention has received substantial att- tion. The decrease in smoking in recent decades has helped, but smoking is not the only problem. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States. Several factors contribute to the lethality of lung cancer, including the rapidity of tumor growth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as discussing our track record to date in exploiting them.

Lung Cancer and Autoimmune Disorders

Lung Cancer and Autoimmune Disorders
A Book

by Mieczyslaw Pokorski

  • Publisher : Springer
  • Release : 2014-11-22
  • Pages : 71
  • ISBN : 3319097520
  • Language : En, Es, Fr & De
GET BOOK

Lung cancer and autoimmune diseases are complex entities in that they involve gene disturbance, gene polymorphism, and impaired gene repair mechanisms. The volume focuses on altered gene expression in tumor processes and in chronic autoimmune disorders. The chapters discuss the biological rationale for novel disease protein markers, present relevant clinical results, and give some diagnostic and therapeutic tips.

Lung Cancer

Lung Cancer
New Understandings and Therapies

by Anne Chiang,Roy S. Herbst

  • Publisher : Humana
  • Release : 2021-08-22
  • Pages : 190
  • ISBN : 9783030740276
  • Language : En, Es, Fr & De
GET BOOK

Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded productive advances in the subsequent treatment. Future advances also include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement.